Biotricity (NASDAQ: BTCY)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Biotricity (NASDAQ: BTCY) through any online brokerage.
The latest price target for Biotricity (NASDAQ: BTCY) was reported by Lake Street on Monday, March 7, 2022. The analyst firm set a price target for 5.00 expecting BTCY to rise to within 12 months (a possible 182.49% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Biotricity (NASDAQ: BTCY) is $1.77 last updated June 30, 2022, 8:00 PM UTC.
A quarterly cash dividend of $0.07 per share of Class A Common Stock. The quarterly cash dividend was payable on April 7, 2022 to stockholders of record on March 28, 2022.
Biotricity’s Q1 earnings are confirmed for Wednesday, August 24, 2022.
There is no upcoming split for Biotricity.
Biotricity is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.